Chloe Cina

Partner, National Security, Morrison Foerster

Deutsche Bank

Chloe Cina, a barrister and leading international financial sanctions expert. She is the Head of Global Sanctions Advisory at Deutsche Bank. Her work includes advising on complex cross-border investigations, enforcement, high profile transactions and sanctions compliance, particularly in the context of Russia, Iran and humanitarian aid. She’s recognised by international organisations, regulators, and the private sector for her thought leadership and legal advisory work. She worked for United Nations. At the Foreign Office she was in the National Security team where she led the Iran nuclear legal team for the UK. At HSBC she was the UK Head of Sanctions.

Branislav Aleksic

Head of Export Control and Corporate Security Department

FRAUNHOFER-GESELLSCHAFT (Germany)

Ghaith Bakdash PhD

Director

Microbiotica

Ghaith Bakdash is an immunologist with broad experience ranging from immune oncology to autoimmune disease and mucosal immunology. Following his PhD at the University of Amsterdam, his interest in translational research led him to a post-doc position at Radboud University Medical Cetner in Nijmegen, the Netherlands, where he contributed to the development of dendritic cell-based cancer vaccines. Later, he joined GSK as an investigator in the Respiratory Therapy Area, where he was participating in the development of new modalities to induce immune tolerance in the context of allergy and asthma. Currently, he is an Associate Director at Microbiotica, where he is leading the efforts of the Cell Biology team in live bacterial therapies development by elucidating the interactions between these therapeutic bacteria and host cells in the context of cancer and ulcerative colitis.

Elisabeth Weis

Associate Vice President, Global Marketing, Fertility

Organon

Elisabeth Weis is responsible for the development and execution of Organon's Fertility Franchise vision, purpose, and long-term strategy, including the unleashing of significant drivers of both organic and inorganic growth. Through effective partnering with senior leader counterparts in both the R&D and Manufacturing organizations, she is focused on maximizing the full potential of Organon's current fertility brands and successfully expanding into new areas through business development acquisitions and strategic partnerships in order to help build families around the world.